Celebrating World IVF Day
Published in Healthcare & Nursing, General & Internal Medicine, and Pharmacy & Pharmacology
World IVF Day is celebrated every year on 25th July to recognise the advances made in fertility medicine since the first successful birth resulting from IVF in 1978. We have collected some of our most impactful articles on IVF and assisted reproductive technology published in Reproductive Biology and Endocrinology in the last few years on our World IVF Day page.
Check out articles on using artificial intelligence models to predict successful live births, diagnosing and managing infertility using NICE adapted guidelines, the debate of fresh versus frozen embryo transfer, and more.
The Journal has also begun publishing in our highly anticipated collection on the use of AI in the IVF and embryology lab. AI has the potential to revolutionise the field of IVF by improving the accuracy of embryo selection, personalising treatment plans, and developing new technologies. However, more research is needed to fully understand the benefits and limitations of AI in IVF, and to ensure that its use is ethical and safe. This collection aims to further our knowledge to inform future policy and practice.
Following the controversial US Supreme Court ruling on the use of embryos in IVF, co-Editor-in-Chief Dr David Seifer provided his thoughts on the decision in an Editorial that discusses the facts of the ruling, the potential implications, a reassurance as to the future of IVF in general, and what we might expect next.
As we celebrate World IVF Day, we recognise not only the scientific breakthroughs that have made parenthood possible for countless families, but also the resilience and hope of those embarking on their fertility journeys. This day stands as a testament to the dedication of medical professionals and researchers who continue to push the boundaries of reproductive health. As we look to the future, it is vital we continue to support and advocate for advancements in fertility treatments, ensuring equity and fairness for all.
Before joining Springer Nature in 2021, Tamara completed an MBio in Biomedical Sciences at the University of Warwick and now manages a portfolio of fully open access journals focused on women's health and implementation science. In addition, she chairs the Springer Nature SDG3 (Good Health and Well-Being) working group.
Follow the Topic
-
Reproductive Biology and Endocrinology
This journal publishes and disseminates high quality results from excellent research in the reproductive sciences.
Related Collections
With Collections, you can get published faster and increase your visibility.
Research Integrity in Reproductive Medicine
Publishing Model: Open Access
Deadline: Ongoing
Advances in Male Reproduction and Andrology
Male factor infertility accounts for approximately half of all infertility cases, yet has received comparatively less diagnostic and research investment than female‑factor infertility. Adoption of the World Health Organization’s sixth-edition semen analysis manual is reshaping laboratory standardization, and advances in genomics, epigenetics, and multi‑omic profiling are providing new explanations for previously idiopathic male infertility.
Current research priorities in andrology include the diagnostic value of oxidative stress and sperm DNA fragmentation testing, artificial intelligence‑assisted semen analysis and sperm retrieval prediction in non‑obstructive azoospermia, evolving criteria for varicocele repair, and the effects of environmental exposures, including endocrine‑disrupting chemicals and microplastics, on sperm quality. Sperm epigenetics and its role in mediating paternal‑age and lifestyle effects on offspring health is another area of active research.
The Collection aims to advance understanding of male reproductive biology and its clinical translation, from the molecular mechanisms of spermatogenesis and sperm function to diagnostic and therapeutic innovation in male infertility. It welcomes contributions from basic science, clinical, epidemiological, and technological perspectives, with the goal of improving diagnostic precision and treatment options for male reproductive disorders.
This Collection welcomes original research articles, narrative reviews, systematic reviews and meta‑analyses, clinical and translational studies, methodological and technology‑validation studies (including artificial intelligence and other novel diagnostic tools), and concise brief reports, in keeping with the journal’s scope.
Topics of interest include, but are not limited to:
- molecular and cellular mechanisms of spermatogenesis, sperm maturation, and sperm function;
- genetic, epigenetic, and multi‑omic approaches to diagnosing idiopathic and non‑obstructive male infertility;
- sperm DNA fragmentation and oxidative stress: mechanisms, clinical utility, and testing standardization;
- seminal plasma and sperm proteomics and biomarker discovery;
- seminal extracellular vesicles and their role in sperm function;
- semen analysis standardization and quality control, including implementation of the WHO’s sixth edition manual;
- artificial intelligence and emerging technologies in semen analysis, sperm selection, and sperm retrieval prediction;
- diagnosis, genetics, and management of non‑obstructive azoospermia, including surgical sperm retrieval;
- varicocele diagnosis and management;
- environmental, occupational, and lifestyle influences on male fertility;
- paternal age and epigenetic contributions to offspring health; and
- endocrine regulation of testicular function and male reproductive ageing.
This Collection supports and amplifies research related to SDG 3: Good Health and Well‑being by advancing understanding of male reproductive health.
All submissions in this collection will undergo the journal’s standard peer review process. Additionally, all manuscripts authored by a Guest Editor(s) are handled by the Editor-in-Chief. We recognize that many key stakeholders may not have access to such resources and are committed to supporting participation in this issue wherever resources are a barrier. For more information about what support may be available, please visit OA funding and support, or email OAfundingpolicy@springernature.com or contact the Editor-in-Chief.
Publishing Model: Open Access
Deadline: Jun 10, 2027
